Hire AI Agent Developer for Biotech Startups
Senior, direct, no layers

The scarcest resource at a biotech startup is focused scientific time. Every hour a scientist spends reformatting data, chasing a CRO, or rebuilding an investor update is an hour not spent on the science the company exists to do. The recurring friction is experimental data scattered across notebooks and drives, CRO results arriving late or in unusable formats, and investor updates rebuilt from scratch every month.

An agent is not a chatbot with a new name. It works across several steps and systems — checking an electronic lab notebook such as Benchling, preparing a brief, booking the next step — and it stops and asks a human whenever the stakes are high or the information is unclear.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, an agent that gathers the scattered details, checks them against an electronic lab notebook such as Benchling, and prepares a single brief with gaps clearly marked would turn a scramble into a short review. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals already cover much of the work at biotech startups. What is usually missing is the routine around them: consistent handoffs, visible status, and checks that catch errors before they reach research partners, investors, and CRO teams.

The agent connects an electronic lab notebook such as Benchling and a LIMS to the team's calendars and document systems, with permissions set so it can only read and write what it is explicitly allowed to. Nothing is sent to a public tool, and every action is logged.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

For a startup like this, success looks like scientists spending time on science, partners getting clean data, and milestones documented well enough to survive diligence.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is the chasing: routine gathering and follow-up happen on their own, and staff step in where judgment matters instead of where typing matters.

Browse all hire engagements or discuss your biotech startup workflow directly.